HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Abstract
Hepatic parenchymal cells respond in many different ways to acute-phase cytokines. Some responses may protect against damage by liver-derived inflammatory mediators. Previous investigations have shown that cytokines cause increased secretion by hepatoma cells of soluble complement regulatory proteins, perhaps providing protection from complement attack. More important to cell protection are the membrane complement regulators. Here we examine, using flow cytometry and Northern blotting, the effects of different cytokines, singly or in combination, on expression of membrane-bound complement regulators by a hepatoma cell line. The combination of tumour necrosis factor-alpha, IL-1beta, and IL-6 caused increased expression of CD55 (three-fold) and CD59 (two-fold) and decreased expression of CD46 at day 3 post-exposure. Interferon-gamma reduced expression of CD59 and strongly antagonized the up-regulatory effects on CD59 mediated by the other cytokines. Complement attack on antibody-sensitized hepatoma cells following a 3-day incubation with the optimum combination of acute-phase cytokines revealed increased resistance to complement-mediated lysis and decreased C3b deposition. During the acute-phase response there is an increased hepatic synthesis of the majority of complement effector proteins. Simultaneous up-regulation of expression of CD55 and CD59 may serve to protect hepatocytes from high local concentrations of complement generated during the acute-phase response.
AuthorsO B Spiller, O Criado-García, S Rodríguez De Córdoba, B P Morgan
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 121 Issue 2 Pg. 234-41 (Aug 2000) ISSN: 0009-9104 [Print] England
PMID10931136 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • CD55 Antigens
  • CD59 Antigens
  • Complement Membrane Attack Complex
  • Interleukin-1
  • Interleukin-6
  • RNA, Messenger
  • RNA, Neoplasm
  • Tumor Necrosis Factor-alpha
  • Complement System Proteins
Topics
  • Acute-Phase Reaction (genetics, immunology)
  • Antigens, Neoplasm (biosynthesis, genetics)
  • CD55 Antigens (biosynthesis, genetics)
  • CD59 Antigens (biosynthesis, genetics)
  • Carcinoma, Hepatocellular (immunology, microbiology, pathology)
  • Complement Membrane Attack Complex (antagonists & inhibitors)
  • Complement System Proteins (immunology)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Interleukin-1 (pharmacology)
  • Interleukin-6 (pharmacology)
  • Liver Neoplasms (immunology, metabolism, pathology)
  • RNA, Messenger (biosynthesis)
  • RNA, Neoplasm (biosynthesis)
  • Tumor Cells, Cultured (drug effects, immunology)
  • Tumor Necrosis Factor-alpha (pharmacology)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: